cancer drugs

May 3, 2021

The study provides insights into how the cancers resist treatments, and which patients may benefit from treatment. 

A new study illuminates the complexity of anticancer drug pricing and several market forces that underlie large price increases in the years after a drug's launch.  The report was published in the May issue of Health Affairs.  The autho

Subscribe to cancer drugs